Financial Gravity Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Financial Gravity Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$65K	Sell	60 -5	-8%	-$67	0.03%	474
2021 Q2	$74K	Buy	+65	New	+$909	0.03%	442
2020 Q4	$2K	Buy	+130	New	+$1.75K	﹤0.01%	338
2019 Q4	$41K	Hold	95	–	–	0.03%	734
2019 Q3	$1K	Sell	95 -25	-21%	-$186	﹤0.01%	1096
2019 Q2	$1K	Sell	120 -485	-80%	-$3.81K	﹤0.01%	1119
2019 Q1	$5K	Buy	+605	New	+$4.6K	﹤0.01%	697
2018 Q3	$1K	Buy	125 +5	+4%	+$33	﹤0.01%	1221
2018 Q2	$1K	Sell	120 -30	-20%	-$189	﹤0.01%	1246
2018 Q1	$1K	Buy	+150	New	+$1.05K	﹤0.01%	1227

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Financial Gravity Asset Management's RDY Position: Q3 2021 in Review

Financial Gravity Asset Management reduced its Dr. Reddy's Laboratories (RDY) stake by 7.7% in Q3 2021, selling an estimated $67 and leaving 60 shares worth $65K. The position accounts for 0.03% of the portfolio, ranked #474.

Financial Gravity Asset Management first reported a position in RDY in Q1 2018 and has held it in 10 quarters since. The position peaked at $74K in Q2 2021. 149 funds tracked by Wall St. Rank hold RDY as of Q3 2021.

Financial Gravity Asset Management held 60 shares of Dr. Reddy's Laboratories worth $65K as of Q3 2021.
Financial Gravity Asset Management sold 5 Dr. Reddy's Laboratories shares in Q3 2021, an estimated $67.
Dr. Reddy's Laboratories made up 0.03% of Financial Gravity Asset Management's portfolio in Q3 2021, its #474 holding.
Financial Gravity Asset Management first reported a position in Dr. Reddy's Laboratories in Q1 2018 and has held it in 10 quarters since.
Financial Gravity Asset Management's Dr. Reddy's Laboratories position peaked at $74K in Q2 2021.
149 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2021.

Based on Financial Gravity Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.